Nitrous oxide

Description

Nitrous Oxide Compressed USP is a colorless, non-flammable gas with a slightly sweet odor and taste. Its chemical name is nitrous oxide, and it has a CAS number of 10024-97-2. The empirical formula for nitrous oxide is N2O.

Uses and Indications

Nitrous Oxide is indicated for use as an anesthetic agent. It is utilized in various medical procedures to provide analgesia and sedation.

There are no specific teratogenic or nonteratogenic effects associated with Nitrous Oxide as per the available data.

Dosage and Administration

Administration of Nitrous Oxide is indicated for use via the respiratory route through inhalation. It is essential that this agent is administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide.

Healthcare professionals must ensure they are familiar with the indications, effects, dosages, methods, and frequency and duration of administration prior to use. Due to the potential hazards and contraindications associated with Nitrous Oxide, careful consideration and adherence to established protocols are imperative to ensure patient safety and efficacy of treatment.

Contraindications

Inhalation of Nitrous Oxide without sufficient oxygen supply is contraindicated due to the risk of fatality or brain damage.

Additionally, exposure to the gas should be avoided; do not breathe in the gas. Contact with liquid Nitrous Oxide in the eyes, on the skin, or on clothing is also contraindicated.

Warnings and Precautions

WARNING: Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas that vigorously accelerates combustion. Exposure to this substance can lead to rapid suffocation and may induce anesthetic effects. Additionally, contact with the liquid form of Nitrous Oxide can result in frostbite.

Administration of Nitrous Oxide should only be performed by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Inhalation of Nitrous Oxide without an adequate supply of oxygen poses a significant risk, potentially leading to fatal outcomes or irreversible brain damage. The release of Nitrous Oxide can dilute the oxygen concentration in the surrounding atmosphere. Physiological responses to Nitrous Oxide exposure, coupled with oxygen deficiency, may impair the ability to respond safely when exposed to Nitrous Oxide concentrations exceeding 10 percent.

CAUTION: It is imperative to avoid inhaling the gas. Adequate ventilation must be ensured during storage and use. Oil and grease should be kept away from the area of use. Direct contact with the liquid form should be avoided to prevent exposure to eyes, skin, or clothing. The temperature of the cylinder must not exceed 125°F (52°C). Only utilize equipment that has been cleaned for Nitrous Oxide and is rated for the appropriate cylinder pressure. The valve should be opened slowly, and all procedures should be conducted in accordance with Med-Tech’s Materials Safety Data Sheet.

FIRST AID: In the event of inhalation, the individual should be removed to fresh air immediately. If the individual is not breathing, artificial respiration should be administered. If breathing difficulties arise, supplemental oxygen should be provided. A physician should be contacted without delay. In cases of frostbite, immediate medical attention is essential.

Side Effects

Inhalation of Nitrous Oxide without sufficient oxygen supply may lead to serious adverse reactions, including fatal outcomes or brain damage. The release of Nitrous Oxide can dilute the oxygen percentage in the atmosphere, creating a hazardous environment. Physiological responses resulting from exposure to Nitrous Oxide and subsequent oxygen deficiency can impair an individual's ability to respond safely when exposed to Nitrous Oxide concentrations exceeding 10 percent.

It is critical for patients and healthcare providers to be aware of these risks to ensure appropriate safety measures are in place during the administration of Nitrous Oxide.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated in pediatric patients. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who has experience in its use and administration, particularly in children. Special precautions should be taken when administering Nitrous Oxide to pediatric patients due to the potential risks associated with its use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Administration of Nitrous Oxide during pregnancy may pose significant risks to both the pregnant patient and the developing fetus. The inhalation of Nitrous Oxide without an adequate supply of oxygen can be fatal or lead to severe neurological damage, highlighting the critical importance of ensuring proper ventilation and oxygenation during its use.

Pregnant patients should be cautioned against exposure to Nitrous Oxide, as it can cause rapid suffocation and may lead to frostbite upon contact with the gas. The use of Nitrous Oxide is contraindicated in situations where there is a risk of inadequate oxygen supply, and it should only be administered by or under the supervision of a licensed practitioner experienced in its use.

Physiological responses to Nitrous Oxide exposure, particularly in the context of oxygen deficiency, may impair the ability to respond safely to concentrations exceeding 10 percent. Therefore, healthcare professionals must exercise caution and ensure that all safety measures are in place to mitigate potential hazards associated with Nitrous Oxide administration in pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there are no specific warnings or recommendations concerning the use of Nitrous Oxide during lactation. Therefore, healthcare professionals may consider the use of Nitrous Oxide in nursing mothers on a case-by-case basis, as no adverse effects on breastfed infants have been documented in the provided information.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert for Nitrous Oxide. Therefore, healthcare professionals should exercise caution when administering this agent to individuals with reduced kidney function, as the absence of data limits the ability to make informed decisions regarding its use in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

Postmarketing experience has indicated that the administration of Nitrous Oxide may pose hazards or be contraindicated in certain situations. Reports have highlighted that inhalation of Nitrous Oxide without an adequate supply of oxygen can lead to fatal outcomes or result in brain damage. Additionally, physiological responses associated with Nitrous Oxide exposure, particularly in the context of oxygen deficiency, may impair the ability to respond safely when exposed to Nitrous Oxide concentrations exceeding 10 percent.

Patient Counseling

Healthcare providers should inform patients that federal law prohibits the dispensing of this medication without a prescription. It is crucial to emphasize the potential hazards associated with Nitrous Oxide, which is classified as a high-pressure oxidizing liquid and gas. Patients should be made aware that it vigorously accelerates combustion, can cause rapid suffocation, and may lead to anesthetic effects or frostbite.

Providers must caution patients that the administration of Nitrous Oxide may be hazardous or contraindicated. It should only be used by or under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be advised that inhalation of Nitrous Oxide without an adequate oxygen supply can be fatal or result in brain damage. The release of Nitrous Oxide can dilute the oxygen percentage in the atmosphere, and physiological responses to Nitrous Oxide exposure and oxygen deficiency may impair the ability to respond safely when exposed to concentrations exceeding 10 percent.

It is important to instruct patients to avoid breathing the gas and to ensure that it is stored and used in well-ventilated areas. They should be reminded to keep oil and grease away from the gas and to avoid contact with liquid Nitrous Oxide on their eyes, skin, or clothing. The cylinder temperature should not exceed 125°F (52°C), and it should only be used with equipment that has been cleaned for Nitrous Oxide and is rated for cylinder pressure. Patients should be advised to open the valve slowly and to use the gas in accordance with Med-Tech’s Materials Safety Data Sheet.

In the event of an emergency, patients should be informed of the first aid measures to take if Nitrous Oxide is inhaled. They should be removed to fresh air, and if not breathing, artificial respiration should be administered. If breathing is difficult, oxygen should be provided, and a physician should be contacted. In cases of frostbite, immediate medical attention is necessary.

Storage and Handling

The product is supplied in a cylinder format, which must be handled with care. It is essential to store and use the cylinder in an area with adequate ventilation to ensure safety during operation. The temperature of the cylinder must not exceed 125°F (52°C) to maintain product integrity and safety.

When utilizing the product, it is crucial to use equipment that has been specifically cleaned for Nitrous Oxide and is rated for the appropriate cylinder pressure. Additionally, when opening the valve, it should be done slowly to prevent any sudden release of gas. Proper adherence to these guidelines will ensure safe and effective use of the product.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by MEDICAL-TECHNICAL GASES, INC.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)